RO106508B1 - Phytotherapeutic medicine meant for non-insulinoindependent diabetes - Google Patents

Abstract

The drug according to the invention consists of 40 parts of Vaccinum folium myrtillis, 30 parts folium Morus alba, 20 parts fructus sinebus sinebus Phaseolus vulgaris and 10 parts folium Betula verrucosa, the parts being expressed in weight, and conditioning can take the form of tablets, capsules or powder.

Description

The present invention relates to a phytotherapeutic drug for the treatment of non-insulin-dependent diabetes mellitus, aimed at preserving insulin secretory capacity, at least in the first 5 stages of the disease, and in particular in obese persons.

Herbal medicinal compositions used in the treatment of diabetes are known, such as, the association between Herb Colega, Folium Mirtilli, Fructus Phaseoli sine seeds, Folium Juglandis, Folium Morus and ingredients or the association between Folium Myrlilli, Folium Bethulae, Folium Urtica and Fructus Pha- 15 seeds self-seeding.

The advantage of the drug composition and of the present invention is that it occurs in all the endocrine-metabolic links involved in the modification of the physiological glucostat. The product is well supported by the body, glycemic decreases (even when marked) have never reached below 100 mg / dl and no signs of hypoglyca- 25 ml have been recorded.

According to the invention, it consists of 40 parts Folium Vaccinum myrtillis, 30 parts Folium Morus alba, 20 parts Fructus sine sinebus Phaseolus vul- 30 garis and 10 parts FoliumBetula verrucosa, the parts being expressed by weight, and the conditioning may be in the form of tablets. or powder.

The following is an example of an embodiment of the invention.

In order to obtain the medicinal product according to the invention, the following ingredients are combined in the form of a fine powder: 40 gFolium Vaccinum myrtillis (blueberry), 30 g Folium Morus alba (white worm), 20 g Fructus sine sinebus Phaseolus vulgaris (beans) and 10 g Folium Betulae verrucosa (birch).

The powder may be administered as such or may be packaged as tablets or capsules.

The dose evaluated as effective, according to preliminary tests, was 600 mg three times daily. In most cases, the administration was performed after a prior homogenization, using 2 ... 3 drops of a concentrate obtained from four cereal germs (wheat, corn, barley and rye) and associated with 2 ... 3 drops of milk. The content obtained was well homogenized in a spoon, by rubbing, and the administration was shielded before the morning, lunch and evening tables.

No chemical effects were recorded in the chemical tests, and the values of the biochemical parameters are shown in tables 1 and 2.

Table 1

The variation of the biochemical parameters was studied before or after 3 months of treatment

The parameter set before After treatment Blood glucose (mg / dl) 231 +/- 84 165 +/- 75 HbAi (%) 12.8 +/- 1.3 11.9 +/- 1.2 Total lipid (mg / dl) 1213 +/- 270 1125 +/- 231 Tnglicide (mg / dl) 354 +/- 114 279 +/- 101 Cholesterol (mg / dl) 283 +/- 54 271 +/- 52

Table 2

Blood glucose (mg / dl) and insulinemia (μί /) values recorded in 12 patients during standard lunch

The initial test - time 0 - lh - 2h 221 +/- 76 298 +/- 92 241 +/- 81 18.1 +/- 5 47.3 +/- 11 31.6 +/- 9 The test after 2 months - time 0 174 +/- 69 16.3 +/- 4 - lh 215 +/- 62 53.2 +/- 11 - 2h 181 +/- 58 21.2 +/- 9

Claim

Claims (1)

Claim Phytotherapeutic drug, intended for the treatment of non-sulinodependent diabetes mellitus, based on Myrtilli, Betula Phaseoeus and Morus herbs, characterized in that, in order to achieve good efficacy, it consists of: 40 parts Folium Vaccinum myrtillis, 30 parts Folium Morus alba, 20 parts Fructus sinesinebus Phaseolusvulgaris and 10 parts Folium Betula verrucosa, the parts being expressed by weight, and the conditioning can be in the form of tablets, capsules or powders.